C M. Lee, et.al., VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo., Oncogene, 2009, 28

http://rdf.ncbi.nlm.nih.gov/pubmed/19252526

C M. Lee, et.al., VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo., Oncogene, 2009, 28

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Vhl<tm1.1Wkr>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4436910

class

http://purl.org/net/cito/citesAsAuthority

• Vhl<tm1.1Wkr>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4436910

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• kidney cortex cysts_Vhl<tm1.1Wkr>/Vhl<+>
  http://metadb.riken.jp/0000522I129S4SvJaeC57BL6Vhltm11WkrVhlVhltm11WkrVhl
• embryonic lethality during organogenesis, incomplete penetrance_Vhl<tm1.1Wkr>/Vhl<tm1.1Wkr>
  http://metadb.riken.jp/0011108I129S4SvJaeC57BL6Vhltm11WkrVhltm11WkrVhltm11Wkr
• increased incidence of tumors by chemical induction_Vhl<tm1.1Wkr>/Vhl<+>
  http://metadb.riken.jp/0004499I129S4SvJaeC57BL6Vhltm11WkrVhlVhltm11WkrVhl
• preneoplasia_Vhl<tm1.1Wkr>/Vhl<+>
  http://metadb.riken.jp/0002009I129S4SvJaeC57BL6Vhltm11WkrVhlVhltm11WkrVhl
• increased adenocarcinoma incidence_Vhl<tm1.1Wkr>/Vhl<+>
  http://metadb.riken.jp/0009308I129S4SvJaeC57BL6Vhltm11WkrVhlVhltm11WkrVhl
• abnormal blood vessel morphology_Vhl<tm1.1Wkr>/Vhl<+>
  http://metadb.riken.jp/0001614I129S4SvJaeC57BL6Vhltm11WkrVhlVhltm11WkrVhl